ASX - By Stock
|
PER |
Re:
Comparison Capricor vs. ANP
|
|
Mason14
|
31 |
9.7K |
7 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
31
|
9.7K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
25K |
12M |
15 |
25/09/21 |
25/09/21 |
ASX - By Stock
|
25K
|
12M
|
15
|
|
ASX - By Stock
|
IIQ |
Re:
I am still hearing music - and getting louder
|
|
Mason14
|
252 |
105K |
13 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
252
|
105K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
1.9K |
670K |
40 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
1.9K
|
670K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
162 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
740
|
279K
|
162
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
25K |
12M |
22 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
25K
|
12M
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
28 |
18/09/21 |
18/09/21 |
ASX - By Stock
|
740
|
279K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
85 |
18/09/21 |
18/09/21 |
ASX - By Stock
|
740
|
279K
|
85
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
75 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
740
|
279K
|
75
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
42 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
740
|
279K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
39 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
740
|
279K
|
39
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
1.9K |
670K |
44 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
1.9K
|
670K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
88 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
88
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
21K |
7.6M |
63 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
21K
|
7.6M
|
63
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Dosed in Phase 1b/2 AML Trial
|
|
Mason14
|
245 |
85K |
60 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
245
|
85K
|
60
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
35 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
16 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
65 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
65
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
12 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Mason14
|
127 |
41K |
28 |
05/09/21 |
05/09/21 |
ASX - By Stock
|
127
|
41K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
74 |
05/09/21 |
05/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
74
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Mason14
|
127 |
41K |
87 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
127
|
41K
|
87
|
|
ASX - By Stock
|
IIQ |
Re:
BD1O options - speculative scenarios
|
|
Mason14
|
73 |
27K |
20 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
73
|
27K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
26 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
118
|
40K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
54 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
118
|
40K
|
54
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
82 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
118
|
40K
|
82
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
49 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
118
|
40K
|
49
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
11K |
3.9M |
86 |
31/08/21 |
31/08/21 |
General
|
11K
|
3.9M
|
86
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
74 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
740
|
279K
|
74
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
35 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
740
|
279K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
16 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
740
|
279K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
94 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
740
|
279K
|
94
|
|
ASX - By Stock
|
CUF |
Re:
FEL CHART THREAD
|
|
Mason14
|
310 |
129K |
15 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
310
|
129K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
43 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
118
|
40K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
38 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
118
|
40K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
45 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
118
|
40K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
61 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
118
|
40K
|
61
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
740 |
279K |
91 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
740
|
279K
|
91
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
99 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
99
|
|
ASX - By Stock
|
IIQ |
Re:
BD1 Clinical Efficacy and Valuation Discussion
|
|
Mason14
|
16 |
11K |
33 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
16
|
11K
|
33
|
|
ASX - By Stock
|
CUF |
Re:
Ann: Corporate Presentation
|
|
Mason14
|
24 |
9.4K |
3 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
24
|
9.4K
|
3
|
|
ASX - By Stock
|
CUF |
Re:
Ann: Corporate Presentation
|
|
Mason14
|
24 |
9.4K |
10 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
24
|
9.4K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
52 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
52
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates FTO Melanoma Preclinical Study
|
|
Mason14
|
163 |
59K |
67 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
163
|
59K
|
67
|
|
ASX - By Stock
|
APT |
Re:
Ann: Square, Inc. announces plans to acquire Afterpay
|
|
Mason14
|
883 |
338K |
1 |
07/08/21 |
07/08/21 |
ASX - By Stock
|
883
|
338K
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
11K |
3.9M |
147 |
06/08/21 |
06/08/21 |
General
|
11K
|
3.9M
|
147
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C & Quarterly Activities Report
|
|
Mason14
|
48 |
16K |
35 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
48
|
16K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
30 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
30
|
|